US Drug Recall Register
Class I · High risk Ongoing Initiated Oct 20, 2025 (11 months ago)

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

What was recalled

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Recalling firm
ANTHONY TRINH, 123Herbals LLC
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0388-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chinese recalls

See all